Cargando…

MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma

Detalles Bibliográficos
Autores principales: Loeuillard, Emilien, Gores, Gregory J., Ilyas, Sumera I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413141/
https://www.ncbi.nlm.nih.gov/pubmed/34242622
http://dx.doi.org/10.1016/j.jcmgh.2021.06.019
_version_ 1783747599183904768
author Loeuillard, Emilien
Gores, Gregory J.
Ilyas, Sumera I.
author_facet Loeuillard, Emilien
Gores, Gregory J.
Ilyas, Sumera I.
author_sort Loeuillard, Emilien
collection PubMed
description
format Online
Article
Text
id pubmed-8413141
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84131412021-09-08 MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma Loeuillard, Emilien Gores, Gregory J. Ilyas, Sumera I. Cell Mol Gastroenterol Hepatol Editorial Elsevier 2021-07-06 /pmc/articles/PMC8413141/ /pubmed/34242622 http://dx.doi.org/10.1016/j.jcmgh.2021.06.019 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Editorial
Loeuillard, Emilien
Gores, Gregory J.
Ilyas, Sumera I.
MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma
title MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma
title_full MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma
title_fullStr MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma
title_full_unstemmed MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma
title_short MEK Inhibition: A New Ally in Immunotherapy for Intrahepatic Cholangiocarcinoma
title_sort mek inhibition: a new ally in immunotherapy for intrahepatic cholangiocarcinoma
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413141/
https://www.ncbi.nlm.nih.gov/pubmed/34242622
http://dx.doi.org/10.1016/j.jcmgh.2021.06.019
work_keys_str_mv AT loeuillardemilien mekinhibitionanewallyinimmunotherapyforintrahepaticcholangiocarcinoma
AT goresgregoryj mekinhibitionanewallyinimmunotherapyforintrahepaticcholangiocarcinoma
AT ilyassumerai mekinhibitionanewallyinimmunotherapyforintrahepaticcholangiocarcinoma